☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Cyprium's CUTX-101 Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Menkes Disease
December 15, 2020
Biocryst's Orladeyo (berotralstat) Receives the US FDA's Approval to Prevent Attacks of Hereditary Angioedema (HAE)
December 15, 2020
Myovant's Orgovyx (relugolix) Receives the US FDA's Approval as the First Oral GnRH Receptor Antagonist for Advanced Prostate Canc...
December 15, 2020
MacroGenics' Margenza (margetuximab-cmkb) Receives the US FDA's Patients with Pretreated Metastatic HER2-Positive Breast Cancer
December 15, 2020
Genentech's Ocrevus Shorter 2-Hour Infusion Receives the US FDA's Approval for Relapsing & Primary Progressive Multiple Sclerosis
December 15, 2020
Genentech Signs a Worldwide License Agreement with Relay Therapeutics to Develop and Commercialize RLY-1971
December 15, 2020
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions